BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9081710)

  • 1. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
    Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
    Wendelburg BJ; Vos JM
    Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
    Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
    Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors.
    Mücke S; Draube A; Polack A; Pawlita M; Massoudi N; Staratschek-Jox A; Bohlen H; Bornkamm G; Diehl V; Wolf J
    Int J Cancer; 2000 May; 86(3):301-6. PubMed ID: 10760815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
    Hellebrand E; Mautner J; Reisbach G; Nimmerjahn F; Hallek M; Mocikat R; Hammerschmidt W
    Gene Ther; 2006 Jan; 13(2):150-62. PubMed ID: 16136164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
    Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
    Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term gene expression from autonomously replicating vectors in mammalian cells.
    Wohlgemuth JG; Kang SH; Bulboaca GH; Nawotka KA; Calos MP
    Gene Ther; 1996 Jun; 3(6):503-12. PubMed ID: 8789800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
    Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
    Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery.
    Horlick RA; Sperle K; Breth LA; Reid CC; Shen ES; Robbins AK; Cooke GM; Largent BL
    Protein Expr Purif; 1997 Apr; 9(3):301-8. PubMed ID: 9126600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
    Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
    Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
    Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
    Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
    Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
    Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: induction of bystander killing in vitro and in vivo.
    Westphal EM; Ge J; Catchpole JR; Ford M; Kenney SC
    Cancer Gene Ther; 2000 Jan; 7(1):97-106. PubMed ID: 10678362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
    Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
    Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.